Men and women diagnosed with myelofibrosis. Phase 3.
Age: +18
The patients need to be on a JAK2 Inhibitor for 32 weeks prior to enrollment.
Last 16 weeks on STABLE DAILY dose. They also need RBC Transfusions every 6 weeks.
If you want to participate, fill out the form below in this section
If you want to participate, fill out the form below in this section